CN104109111B - 托西酸贝格列汀及其中间体的制备方法 - Google Patents
托西酸贝格列汀及其中间体的制备方法 Download PDFInfo
- Publication number
- CN104109111B CN104109111B CN201410060560.6A CN201410060560A CN104109111B CN 104109111 B CN104109111 B CN 104109111B CN 201410060560 A CN201410060560 A CN 201410060560A CN 104109111 B CN104109111 B CN 104109111B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- preparation
- reaction
- key intermediate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410060560.6A CN104109111B (zh) | 2013-04-22 | 2014-02-21 | 托西酸贝格列汀及其中间体的制备方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101414550 | 2013-04-22 | ||
CN201310141455.0 | 2013-04-22 | ||
CN201310141455 | 2013-04-22 | ||
CN201410060560.6A CN104109111B (zh) | 2013-04-22 | 2014-02-21 | 托西酸贝格列汀及其中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104109111A CN104109111A (zh) | 2014-10-22 |
CN104109111B true CN104109111B (zh) | 2019-02-12 |
Family
ID=51706122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410060560.6A Active CN104109111B (zh) | 2013-04-22 | 2014-02-21 | 托西酸贝格列汀及其中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104109111B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107805201B (zh) * | 2017-11-03 | 2020-07-28 | 万华化学集团股份有限公司 | 一种二氢茉莉酮酸甲酯的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101094824A (zh) * | 2004-12-15 | 2007-12-26 | 未来化学株式会社 | 在醇溶剂中制备有机氟化物的方法 |
CN101230059A (zh) * | 2007-01-23 | 2008-07-30 | 上海恒瑞医药有限公司 | 双环氮杂烷类衍生物、其制备方法及其在医药上的用途 |
CN101318922A (zh) * | 2007-06-08 | 2008-12-10 | 上海阳帆医药科技有限公司 | 一类新型二肽基肽酶抑制剂、合成方法和用途 |
US20080318923A1 (en) * | 2005-01-28 | 2008-12-25 | Taisho Pharmaceutical Co., Ltd. | 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle |
WO2010007363A2 (en) * | 2008-07-15 | 2010-01-21 | Isis Innovation Limited | Preparation of fluorine-labelled compounds |
CN103508931A (zh) * | 2012-06-25 | 2014-01-15 | 广东东阳光药业有限公司 | 六氢并环戊二烯衍生物、其制备方法及其在医药上的应用 |
-
2014
- 2014-02-21 CN CN201410060560.6A patent/CN104109111B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101094824A (zh) * | 2004-12-15 | 2007-12-26 | 未来化学株式会社 | 在醇溶剂中制备有机氟化物的方法 |
US20080318923A1 (en) * | 2005-01-28 | 2008-12-25 | Taisho Pharmaceutical Co., Ltd. | 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle |
CN101230059A (zh) * | 2007-01-23 | 2008-07-30 | 上海恒瑞医药有限公司 | 双环氮杂烷类衍生物、其制备方法及其在医药上的用途 |
CN101318922A (zh) * | 2007-06-08 | 2008-12-10 | 上海阳帆医药科技有限公司 | 一类新型二肽基肽酶抑制剂、合成方法和用途 |
WO2010007363A2 (en) * | 2008-07-15 | 2010-01-21 | Isis Innovation Limited | Preparation of fluorine-labelled compounds |
CN103508931A (zh) * | 2012-06-25 | 2014-01-15 | 广东东阳光药业有限公司 | 六氢并环戊二烯衍生物、其制备方法及其在医药上的应用 |
Non-Patent Citations (4)
Title |
---|
A New Class of SN2 Reactions Catalyzed by Protic Solvents:Facile Fluorination for Isotopic Labeling of Diagnostic Molecules;Dong Wook Kim,等;《J. AM. CHEM. SOC.》;20061123;第128卷;16394-16397 |
Nucleophilic Fluorination of Triflates by Tetrabutylammonium Bifluoride;Kyu-Young Kim,等;《J. Org. Chem.》;20080923;第73卷;8106–8108 |
Studies of the Solid-Phase Pauson-Khand Reaction:Selective in-situ Enone Reduction to 3-Azabicyclo[3.3.0]octanones;Daniel P. Becker,等;《Tetrahedron letters》;19931231;第34卷(第13期);2087-2090 |
Temperature effects on the stereospecificity of nucleophilic fluorination: formation of trans-[18F]4-fluoro-L-proline during the synthesis of cis-[18F]4-fluoro-L-proline;Babak Behnam Azad,等;《J. Label Compd. Radiopharm》;20111103;第55卷;23–28 |
Also Published As
Publication number | Publication date |
---|---|
CN104109111A (zh) | 2014-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019400110B2 (en) | Radioactive fluorine-labeled Larotrectinib compound and preparation method therefor | |
JP5791636B2 (ja) | エンテカビルおよびその中間体を調製するための方法 | |
CN101863948B (zh) | 高纯度(2β,3α,5α,16β,17β)-2-(4-吗啉基)-16-(1-吡咯烷基)-雄甾烷-3,17-二醇或其组合物及其制备方法 | |
CN104447934B (zh) | 一种醋酸阿比特龙的纯化方法 | |
CN104418807A (zh) | 一种2-乙氧基-1-[[2`-(羟基脒基)-联苯基]-4-基]甲基-1h-苯并咪唑-7-羧酸及其酯衍生物的制备方法 | |
JP2018532718A (ja) | ホスホルアミダート化合物及びその製造方法並びに結晶 | |
CN108863958A (zh) | 一种4,7-二氮杂螺[2.5]辛烷衍生物的制备方法 | |
CN104109111B (zh) | 托西酸贝格列汀及其中间体的制备方法 | |
CN109608468A (zh) | 一种枸橼酸托法替布杂质及其合成方法和用途 | |
CN104163787A (zh) | 阿扎那韦及其硫酸盐的制备方法 | |
CN106632275B (zh) | 一种雷迪帕韦的制备方法及制备雷迪帕韦的中间体 | |
CN109071551A (zh) | 一种三氟甲基取代的吡喃衍生物的制备方法 | |
CN106349229B (zh) | 雷迪帕韦中间体的制备方法及中间体化合物 | |
CN103467449B (zh) | 一种哌啶衍生物、制备方法及在制备常山酮中的应用 | |
CN103342707B (zh) | 用于制备阿塞纳平中间体的制备方法 | |
CN109553610A (zh) | 一种恩曲他滨异构体的制备方法 | |
CN113501758B (zh) | 一种联苯化合物的制备方法 | |
CN106146535A (zh) | 一种依维莫司的制备方法 | |
CN105017251B (zh) | 一种nk-1受体拮抗剂的制备方法及其中间体 | |
WO2021100730A1 (ja) | ピロリジン化合物の製造方法 | |
CN107353266B (zh) | 一种烯酸溴内酯化的制备方法 | |
CN107365310A (zh) | 具有吡啶酮结构的新型法尼基转移酶抑制剂的制备方法 | |
CN104447178B (zh) | 一种3,4-二苯并蒽的合成方法 | |
CN107312000A (zh) | 具有4,5‑二氢‑1,2,3‑三氮唑结构的新型法尼基转移酶抑制剂的制备方法 | |
CN108727266A (zh) | 一种伊伐布雷定杂质的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Applicant after: SHANGHAI JIESEN PHARMACEUTICAL CHEMISTRY TECHNOLOGY Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. Applicant before: SHANGHAI JIESEN PHARMACEUTICAL CHEMISTRY TECHNOLOGY Co.,Ltd. |
|
COR | Change of bibliographic data | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Applicant after: SHANGHAI HANSOH BIOMEDICAL Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Applicant before: SHANGHAI JIESEN PHARMACEUTICAL CHEMISTRY TECHNOLOGY Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Applicant after: SHANGHAI JIESEN PHARMACEUTICAL CHEMISTRY TECHNOLOGY Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Applicant before: SHANGHAI JIESEN PHARMACEUTICAL CHEMISTRY TECHNOLOGY Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C10 | Entry into substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160426 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: SHANGHAI HANSOH BIOMEDICAL Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Applicant before: SHANGHAI HANSOH BIOMEDICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |